Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06424301	Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma	recruiting	Early Phase 1	2	Eye & ENT Hospital of Fudan UniversityOTHER	1	Jun 26, 2025	clinicaltrials
NCT05380349	Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma	recruiting	Early Phase 1	10	Swedish Medical CenterOTHER	1	May 16, 2025	clinicaltrials